New Strategies in Cancer Immunotherapy

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Oncology".

Deadline for manuscript submissions: 10 August 2026 | Viewed by 64

Special Issue Editor

Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
Interests: chemoradiotherapy; immune cell therapy; tumor biology; immunotherapy
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Background and history of this topic: Cancer immunotherapy has reshaped the oncology landscape, offering transformative clinical benefits. However, durable and broadly effective responses remain limited due to tumor heterogeneity, immune-evasion mechanisms, and constraints of current therapeutic modalities. Rapid progress in cellular engineering, multi-omics technologies, and tumor microenvironment reprogramming has created new opportunities to overcome these challenges.

Aim and scope of the special issue: This Special Issue, “New Strategies in Cancer Immunotherapy”, aims to present advances that enhance understanding of immune regulation, introduce innovative therapeutic concepts, and translate mechanistic insights into improved clinical applications. The scope includes basic, translational, and clinical research addressing next-generation immunotherapeutic strategies.

Cutting-edge research: Key areas of innovation include engineered cellular therapies, multi-omics–driven target discovery, modulation of the tumor microenvironment, personalized cancer vaccines, bispecific immunotherapeutic platforms, and biomarker-guided combination approaches. These efforts aim to deliver more precise, potent, and durable antitumor responses.

What kind of papers we are soliciting: We seek original research articles, comprehensive reviews, and translational studies that

  1. Elucidate immune mechanisms relevant to cancer therapy;
  2. Propose novel immunotherapeutic targets or strategies;
  3. Present preclinical or clinical evidence supporting emerging approaches;
  4. Integrate multi-omics, engineering, or biomarker-driven methods;
  5. Explore rational combination therapies and mechanisms of resistance.

Dr. Chiwen Luo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer immunotherapy
  • immune modulation
  • tumor microenvironment
  • immune checkpoints
  • cellular therapies
  • personalized vaccines
  • biomarkers
  • combination strategies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop